Environmental exposures during early life influence adult disease risk – Open Access Government
Posted: October 14, 2019 at 5:53 pm
An individuals experiences during early life can influence their risk for disease as an adult. Dr. David Barker first postulated this in the 1980s following his observations that infants born with low birth weight were at significantly increased risk for developing cardiovascular disease as adults. This idea was controversial at the time because it challenged the conventional thinking that unhealthy lifestyle was the primary cause of cardiovascular disease. However, subsequent epidemiologic studies confirmed Barkers findings and the concept that early-life experiences are an important determinant of adult disease risk became known as the Barker hypothesis.
While the Barker hypothesis was derived from evidence linking foetal malnutrition to cardiovascular disease risk in adulthood, the concept has since expanded to include a broader spectrum of risk factors, diverse disease states targeting different organ systems, and developmental periods extending beyond gestation. In recognition of this paradigm shift, the Barker hypothesis was renamed the developmental origins of health and disease (DOHaD) hypothesis. Several decades of DOHaD research have identified at least four categories of early-life risk factors: the nutritional status of the pregnant woman and young child, psychosocial stress, immunological stress, particularly infection during pregnancy, and chemical exposures. It is now also appreciated that the risk of most, if not all, adult-onset diseases are influenced by early-life stress, but only if exposures occur during specific periods of development. These high-risk periods are referred to as critical periods or critical windows of development, and these vary depending on the early-life insult and the target organ. For many organ systems, however, the foetal period is the primary critical window.
The nervous system is particularly vulnerable to early-life stressors, perhaps because human brain development continues after birth, throughout early childhood and into adolescence. To date, research supports an association between early-life environmental insults and increased risk of neuropsychiatric disorders like schizophrenia, demyelinating diseases, such as multiple sclerosis (MS), and neurodegenerative diseases, such as Alzheimers and Parkinsons diseases (AD and PD, respectively). Whether an early-life stressor increases an individuals risk for neuropsychiatric or neurologic disease depends on numerous factors. What is the type and magnitude of the stressor? Is the insult continuous, intermittent, or a single isolated incident? What is the timing of exposure relative to critical windows of development, which vary across different brain regions? Does the affected individual carry genes that confer increased susceptibility or increased resistance to the adverse effects of the stressor? Sex also influences the impacts of early-life stressors, perhaps because gonadal sex hormones influence many of the organisational aspects of neurodevelopment. Examining the sex-specificity of early-life stressors may be important for understanding why many neurological and neuropsychiatric diseases exhibit a sex bias in their incidence and clinical profile.
Maternal infection during pregnancy is strongly linked to increased risk of schizophrenia, though it does not appear that any specific pathogen or class of pathogens is responsible. While there is disagreement as to whether a specific trimester of pregnancy is most vulnerable, the pro-inflammatory environment created by maternal infection is thought to alter the pattern of cellular connections made in the foetal brain, laying the groundwork for altered behavior in adulthood. Emerging evidence also suggests that early-life exposure to the lead (Pb) may increase risk for schizophrenia, particularly in individuals that express a mutation in the disrupted in schizophrenia 1 (DISC-1) gene, a gene that is strongly associated with schizophrenia and related mental disorders. AD is the most common cause of progressive dementia in elderly adults and it is rapidly increasing in global incidence; PD is the second most common neurodegenerative disease after AD. Only a small percentage of cases of either disease can be attributed to solely genetic causes, supporting a role for environmental factors in determining individual risk. Recent studies have identified early-life risk factors for AD and PD, including low birth weight, premature birth, living in a rural area, low socioeconomic status during childhood, and prenatal or early childhood exposures to environmental pollutants, including heavy metals, pesticides, and air pollution. Air pollution has also been linked to an increased risk of MS.
A key question in the field is how do early-life events influence risk of adult-onset disease? It is believed that environmental stressors disrupt the organisational patterning and/or function of the developing brain by altering cell numbers or interfering with the differentiation of neurons or glial cells. So why do these changes not manifest as functional deficits or disease until adulthood? One explanation is that the affected cells are not functional until later in life. For example, exposure of the developing brain to high concentrations of the food additive monosodium glutamate (MSG) causes excessive death of neurons in the hypothalamus by triggering apoptosis, a form of programmed cell death. However, functional deficits associated with the foetal loss of these hypothalamic neurons (hypogonadism and infertility) become evident only in adolescence when the neuroendocrine function of these neurons is normally activated. Alternatively, the adverse impacts of the early-life stressor are masked or initially attenuated due to compensatory mechanisms or plasticity of the brain. However, these developmental perturbations predispose the individual to neural deficits following subsequent insults, such as chemical exposure, disease, or aging due to decreased brain reserve capacity. This phenomenon has been demonstrated in both animal models and humans following developmental exposures to methyl mercury or pesticides.
In summary, the experimental evidence indicates that early-life insults can fundamentally change the trajectory of brain development, thereby diminishing the ability of the brain to protect against subsequent insults, which increases susceptibility to disease in adulthood. A significant challenge in the field is to identify early-life stressors that increase adult-onset disease in humans. Detecting effects in the human population is difficult because the effects do not manifest until well after the developmental exposure. However, the effort to identify these associations merits investment of research dollars because preventing disease by identifying and reducing or eliminating risk factors is more effective than treating disease in terms of both individual and societal costs.
Please note: This is a commercial profile
Editor's Recommended Articles
Read more here:
Environmental exposures during early life influence adult disease risk - Open Access Government
- What is Male Hypogonadism? Learn Hormone.org's ... [Last Updated On: May 4th, 2015] [Originally Added On: May 4th, 2015]
- Prevalence, Diagnosis and Treatment of Hypogonadism in ... [Last Updated On: May 4th, 2015] [Originally Added On: May 4th, 2015]
- Hypogonadism: Types, Causes, & Symptoms Healthline [Last Updated On: May 4th, 2015] [Originally Added On: May 4th, 2015]
- Hypogonadism - Wikipedia, the free encyclopedia [Last Updated On: May 4th, 2015] [Originally Added On: May 4th, 2015]
- Hypogonadotropic hypogonadism - Wikipedia, the free ... [Last Updated On: May 12th, 2015] [Originally Added On: May 12th, 2015]
- Male hypogonadism Tests and diagnosis - Mayo Clinic [Last Updated On: May 25th, 2015] [Originally Added On: May 25th, 2015]
- Male hypogonadism Symptoms - Mayo Clinic [Last Updated On: May 29th, 2015] [Originally Added On: May 29th, 2015]
- Male hypogonadism: Symptoms and treatment [Last Updated On: June 13th, 2015] [Originally Added On: June 13th, 2015]
- Low Testosterone in Men | Hypogonadism [Last Updated On: June 19th, 2015] [Originally Added On: June 19th, 2015]
- hypogonadism | pathology | Britannica.com [Last Updated On: July 23rd, 2015] [Originally Added On: July 23rd, 2015]
- Hypergonadotropic hypogonadism - Wikipedia, the free ... [Last Updated On: August 1st, 2015] [Originally Added On: August 1st, 2015]
- Hypogonadism | Disorders | Knowledge Base [Last Updated On: September 14th, 2015] [Originally Added On: September 14th, 2015]
- Male Hypogonadism - Cleveland Clinic [Last Updated On: October 7th, 2015] [Originally Added On: October 7th, 2015]
- Male hypogonadism Causes - Mayo Clinic [Last Updated On: October 13th, 2015] [Originally Added On: October 13th, 2015]
- Association of hypogonadism with vitamin D status: the ... [Last Updated On: February 15th, 2016] [Originally Added On: February 15th, 2016]
- What Is Low Testosterone? - Male Hypogonadism Symptoms and ... [Last Updated On: February 27th, 2016] [Originally Added On: February 27th, 2016]
- Hypogonadism | University of Maryland Medical Center [Last Updated On: March 11th, 2016] [Originally Added On: March 11th, 2016]
- Male Hypogonadism | Uroweb [Last Updated On: March 21st, 2016] [Originally Added On: March 21st, 2016]
- Hypogonadism | Conditions & Treatments | UCSF Medical Center [Last Updated On: March 29th, 2016] [Originally Added On: March 29th, 2016]
- Hypogonadism - Medscape [Last Updated On: March 29th, 2016] [Originally Added On: March 29th, 2016]
- Treatment Options for Hypogonadism Healthline [Last Updated On: March 29th, 2016] [Originally Added On: March 29th, 2016]
- Hypogonadism Causes Infertility. Learn how to detect and ... [Last Updated On: May 6th, 2016] [Originally Added On: May 6th, 2016]
- Hypogonadism - FPnotebook.com [Last Updated On: May 6th, 2016] [Originally Added On: May 6th, 2016]
- Testosterone treatment of male hypogonadism - UpToDate [Last Updated On: May 6th, 2016] [Originally Added On: May 6th, 2016]
- EFPIA - Hypogonadism [Last Updated On: May 6th, 2016] [Originally Added On: May 6th, 2016]
- Hypogonadism - RightDiagnosis.com [Last Updated On: May 6th, 2016] [Originally Added On: May 6th, 2016]
- Hypogonadotropic hypogonadism - Wikipedia, the free encyclopedia [Last Updated On: May 6th, 2016] [Originally Added On: May 6th, 2016]
- Hypogonadism Symptoms, Diagnosis, Treatments and Causes ... [Last Updated On: June 1st, 2016] [Originally Added On: June 1st, 2016]
- Compare 37 Hypogonadism, Male Medications | Drugs.com [Last Updated On: July 3rd, 2016] [Originally Added On: July 3rd, 2016]
- Male Hypogonadism - Genitourinary Disorders - Merck ... [Last Updated On: July 10th, 2016] [Originally Added On: July 10th, 2016]
- Hypogonadism - Medscape Reference [Last Updated On: July 15th, 2016] [Originally Added On: July 15th, 2016]
- Hypogonadism and Hypogonadism Resources - What is ... [Last Updated On: July 17th, 2016] [Originally Added On: July 17th, 2016]
- Testosterone Deficiency, Hypogonadism | Froedtert Hospital ... [Last Updated On: July 17th, 2016] [Originally Added On: July 17th, 2016]
- Hypogonadism diagnosis - history - Endobible [Last Updated On: July 17th, 2016] [Originally Added On: July 17th, 2016]
- Hypogonadism - Risks, Symptoms and Leading Causes | Treato [Last Updated On: July 17th, 2016] [Originally Added On: July 17th, 2016]
- Lipocine - Hypogonadism [Last Updated On: July 17th, 2016] [Originally Added On: July 17th, 2016]
- Hypogonadism - Definition, Causes, Symptoms and Treatment [Last Updated On: July 17th, 2016] [Originally Added On: July 17th, 2016]
- HIV and Testosterone Deficiency - verywell.com [Last Updated On: July 17th, 2016] [Originally Added On: July 17th, 2016]
- Hypogonadism - UT Medical Center [Last Updated On: July 17th, 2016] [Originally Added On: July 17th, 2016]
- Diagnosis of Hypogonadism: Clinical Assessments and ... [Last Updated On: July 20th, 2016] [Originally Added On: July 20th, 2016]
- Hypogonadism - Wikipedia [Last Updated On: October 25th, 2016] [Originally Added On: October 25th, 2016]
- Hypergonadotropic hypogonadism - Wikipedia [Last Updated On: November 26th, 2016] [Originally Added On: November 26th, 2016]
- Hypogonadism No Moustache! No Beard [Last Updated On: December 7th, 2016] [Originally Added On: December 7th, 2016]
- You & Your Hormones | Endocrine conditions | Male hypogonadism [Last Updated On: December 29th, 2016] [Originally Added On: December 29th, 2016]
- Posters to Be Presented at the Endocrine Society 2017 Annual Meeting - Business Wire (press release) [Last Updated On: February 8th, 2017] [Originally Added On: February 8th, 2017]
- Low Testosterone Products Litigation - US Recall News (press release) [Last Updated On: February 10th, 2017] [Originally Added On: February 10th, 2017]
- Testosterone therapy provides protection against cardiovascular disease in men with low testosterone - Science Daily [Last Updated On: February 15th, 2017] [Originally Added On: February 15th, 2017]
- Hypogonadism in Reproductive Years - Renal and Urology News [Last Updated On: February 15th, 2017] [Originally Added On: February 15th, 2017]
- Latest Research Predicts Endocrinology Drugs Market in Nascent Stage set for advancing growth by 2021 - Satellite PR News (press release) [Last Updated On: February 16th, 2017] [Originally Added On: February 16th, 2017]
- Testosterone therapy may help prevent heart disease - Bel Marra Health [Last Updated On: February 17th, 2017] [Originally Added On: February 17th, 2017]
- Studies show testosterone offers little benefits to aging men - Ars Technica [Last Updated On: February 21st, 2017] [Originally Added On: February 21st, 2017]
- New studies fail to change 'unfavorable balance' of risks/benefits of testosterone supplements - MinnPost [Last Updated On: February 23rd, 2017] [Originally Added On: February 23rd, 2017]
- Testosterone treatment and coronary artery plaque volume in older men with low testosterone - Pharmacy Today, American Pharmacists Association,... [Last Updated On: February 24th, 2017] [Originally Added On: February 24th, 2017]
- A study to evaluate the prevalence of hypogonadism in Indian males with Type-2 diabetes mellitus. - UroToday [Last Updated On: February 27th, 2017] [Originally Added On: February 27th, 2017]
- 8 things you need to know about testosterone and 'the male menopause' - Netdoctor [Last Updated On: February 28th, 2017] [Originally Added On: February 28th, 2017]
- Antares Pharma Announces FDA Acceptance of New Drug Application for Quickshot Testosterone - P&T Community [Last Updated On: February 28th, 2017] [Originally Added On: February 28th, 2017]
- Increased Plaque Volume on CCTA in Older Men Who Use Testosterone Gel - Diagnostic Imaging [Last Updated On: March 1st, 2017] [Originally Added On: March 1st, 2017]
- Denosumab is really effective in the treatment of osteoporosis secondary to hypogonadism in prostate carcinoma ... - UroToday [Last Updated On: March 2nd, 2017] [Originally Added On: March 2nd, 2017]
- Declining libido? This may be the cause - Bel Marra Health [Last Updated On: March 3rd, 2017] [Originally Added On: March 3rd, 2017]
- USADA notifies Ben Rothwell of potential anti-doping violation, putting UFC 211 status in jeopardy - MMAjunkie.com [Last Updated On: March 8th, 2017] [Originally Added On: March 8th, 2017]
- Family strength helps Brandon Ramirez persevere - Progress Index [Last Updated On: March 11th, 2017] [Originally Added On: March 11th, 2017]
- TRT and heart health: Conflicting findings published - ModernMedicine [Last Updated On: March 18th, 2017] [Originally Added On: March 18th, 2017]
- Efficacy and safety of testosterone replacement gel for treating hypogonadism in men: Phase III open-label studies. - UroToday [Last Updated On: March 19th, 2017] [Originally Added On: March 19th, 2017]
- Testosterone therapy has positive effects on anthropometric measures, metabolic syndrome components (obesity, lipid ... - UroToday [Last Updated On: March 19th, 2017] [Originally Added On: March 19th, 2017]
- JAMA confirms DTC drove 'Low-T' craze - BioPharma Dive [Last Updated On: March 23rd, 2017] [Originally Added On: March 23rd, 2017]
- Ads for low-testosterone treatments benefit sales but not necessarily health - Science Daily [Last Updated On: March 28th, 2017] [Originally Added On: March 28th, 2017]
- Sport and male sexuality. - UroToday [Last Updated On: March 28th, 2017] [Originally Added On: March 28th, 2017]
- A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management. - UroToday [Last Updated On: April 3rd, 2017] [Originally Added On: April 3rd, 2017]
- Infertility - Causes - NHS Choices [Last Updated On: April 7th, 2017] [Originally Added On: April 7th, 2017]
- Recent research: Male hypogonadism - strategic assessment and ... - WhaTech [Last Updated On: April 15th, 2017] [Originally Added On: April 15th, 2017]
- Testosterone level and endothelial dysfunction in patients with vasculogenic erectile dysfunction. - UroToday [Last Updated On: April 18th, 2017] [Originally Added On: April 18th, 2017]
- XOMA Announces Positive Results from its Phase 2 Proof-Of ... - Yahoo Finance [Last Updated On: April 24th, 2017] [Originally Added On: April 24th, 2017]
- Impact of metabolic status on the association of serum vitamin D with hypogonadism and lower urinary tract symptoms ... - UroToday [Last Updated On: April 25th, 2017] [Originally Added On: April 25th, 2017]
- Global Male Hypogonadism Market, 20162024: Type. Size, Share, Trends & Forecast Report - MilTech [Last Updated On: April 26th, 2017] [Originally Added On: April 26th, 2017]
- Global Male Hypogonadism Market, 20162024: Type. Size, Share, Trends & Forecast Report - satPRnews (press release) [Last Updated On: April 27th, 2017] [Originally Added On: April 27th, 2017]
- Aytu BioScience to Provide Fiscal Third Quarter 2017 Business Update - PR Newswire (press release) [Last Updated On: May 3rd, 2017] [Originally Added On: May 3rd, 2017]
- What's in the Cards for Repros (RPRX) this Earnings Season? - Zacks.com [Last Updated On: May 5th, 2017] [Originally Added On: May 5th, 2017]
- Testosterone Replacement Therapy May Protect Against Stroke, Heart Attack in Hypogonadism - Endocrinology Advisor [Last Updated On: May 5th, 2017] [Originally Added On: May 5th, 2017]
- In Hypogonadism, Stroke May Be Prevented With Testosterone Replacement Therapy - Neurology Advisor [Last Updated On: May 9th, 2017] [Originally Added On: May 9th, 2017]
- AYTU BIOSCIENCE, INC. (OTCMKTS:AYTU) Files An 8-K Entry into a Material Definitive Agreement - Market Exclusive [Last Updated On: May 10th, 2017] [Originally Added On: May 10th, 2017]